DUET
DEAD

Serial Number

90484167

Owner

bluDiagnostics LLC

Attorney

Susan M. Kayser

Filing Date

Jan 23, 2021

Add to watchlist:

No watchlists yet
View on USPTO

DUET Trademark

Serial Number: 90484167

DUET is a trademark filed by bluDiagnostics LLC on January 23, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

bluDiagnostics LLC (2 trademarks)

Cupertino, CA 95014

Entity Type: 16

Trademark Details

Filing Date

January 23, 2021

Registration Date

Not Registered

Published for Opposition

October 5, 2021

Goods & Services

Research laboratory analyzers for measuring, testing and analyzing saliva and other bodily fluids; electronic readers for measuring, testing and analyzing saliva and other bodily fluids; cloud connected electronic readers for testing and analyzing saliva and other bodily fluids; Downloadable cloud computing software for storing, transmitting, and analyzing data in the cloud; Portable and handheld digital electronic devices for recording, organizing, transmitting, manipulating, analyzing and reviewing medical data; Computer hardware and recorded software sold as a unit for use with medical patient testing equipment, for receiving, processing, analyzing, transmitting and displaying data; downloadable software application for viewing, transmitting, and analyzing medical data and test results; downloadable software application allowing patients and medical providers to view, transmit, receive, and analyze medical data and test results

Medical diagnostic test strips and cartridges for saliva and hormone analysis; Medical diagnostic test strips and cartridges for use in the field of detecting respiratory viruses and other infectious, viral, inflammatory, immunological, autoimmune, and cardiovascular illness; Medical diagnostic reagents and assays for testing of body fluids; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, infectious, viral, inflammatory, immunological, autoimmune, respiratory, and cardiovascular illness

Medical diagnostic testing, monitoring and reporting services; Medical testing for diagnostic or treatment purposes in the field of infectious, viral, inflammatory, immunological, autoimmune, respiratory, and cardiovascular illness; Medical testing for diagnostic or treatment purposes

Medical diagnostic apparatus for testing infectious, viral, inflammatory, immunological, autoimmune, respiratory, and cardiovascular illness; Medical diagnostic apparatus for testing infectious, viral, inflammatory, immunological, autoimmune, respiratory, and cardiovascular illness incorporating recorded operating system software; Medical diagnostic apparatus for at-home testing for infectious, viral, inflammatory, immunological, autoimmune, respiratory, and cardiovascular illness; Medical diagnostic apparatus for rapid response testing for infectious, viral, inflammatory, immunological, autoimmune, respiratory, and cardiovascular illness; Medical diagnostic apparatus for testing infectious, viral, inflammatory, immunological, autoimmune, respiratory, and cardiovascular illness incorporating recorded software for analyzing and reporting data to patients and medical providers; Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial and hormone testing

Scientific and technological services, namely, analysis and testing in the field of medical diagnostics; Cloud computing featuring software for use in analyzing and reporting test results in the field of medicine; Providing temporary use of on-line non-downloadable cloud computing software for use in analysis, reporting, and electronic storage of data in the field of medicine; Providing temporary use of non-downloadable cloud-based software for analyzing medical test results

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jan 6, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jan 6, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 9, 2024 EXRA
SOU EXTENSION 5 GRANTED
May 8, 2024 EX5G
SOU EXTENSION 5 FILED
May 8, 2024 EXT5
SOU TEAS EXTENSION RECEIVED
May 8, 2024 EEXT
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
May 2, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 2, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 2, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 2, 2024 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 27, 2023 EXRA
SOU EXTENSION 4 GRANTED
Oct 24, 2023 EX4G
SOU EXTENSION 4 FILED
Oct 24, 2023 EXT4
SOU TEAS EXTENSION RECEIVED
Oct 24, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 4, 2023 EXRA
SOU EXTENSION 3 GRANTED
May 2, 2023 EX3G
SOU EXTENSION 3 FILED
May 2, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
May 2, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 4, 2022 EXRA
SOU EXTENSION 2 GRANTED
Nov 2, 2022 EX2G
SOU EXTENSION 2 FILED
Nov 2, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 2, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 7, 2022 EXRA
SOU EXTENSION 1 GRANTED
May 5, 2022 EX1G
SOU EXTENSION 1 FILED
May 5, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
May 5, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 30, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 5, 2021 NPUB
PUBLISHED FOR OPPOSITION
Oct 5, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 15, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 2, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 2, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 2, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 2, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 2, 2021 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 1, 2021 GNRN
NON-FINAL ACTION E-MAILED
Sep 1, 2021 GNRT
NON-FINAL ACTION WRITTEN
Sep 1, 2021 CNRT
ASSIGNED TO EXAMINER
Aug 23, 2021 DOCK
ASSIGNED TO EXAMINER
Aug 9, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 24, 2021 NWOS
NEW APPLICATION ENTERED
Jan 27, 2021 NWAP